FTC sues significant pharmacy benefit managers around insulin prices The company introduced motion towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record price of existence-preserving insulin drugs. Sanders swiftly condemned the go in a statement Wednesday, noting he was disappointed but https://label-the-figure-with-the40505.mdkblog.com/36346341/not-known-facts-about-healthcare-news